Copyright
©The Author(s) 2016.
World J Exp Med. Feb 20, 2016; 6(1): 21-36
Published online Feb 20, 2016. doi: 10.5493/wjem.v6.i1.21
Published online Feb 20, 2016. doi: 10.5493/wjem.v6.i1.21
Age |
Ethnicity |
Male Gender |
Liver cirrhosis |
Chronic HBV infection |
Chronic HCV infection |
Hemochromatosis |
Alcoholism |
Aflatoxin-B1 intoxication |
Tyrosinemia, galactosidemia, fructosemia |
Alpha1 anti-trypsin deficiency |
Genetics predisposition |
Anabolizing hormones |
Estrogen contraceptives |
Obesity |
Type II diabetes |
Glucose overload |
Metabolic syndrome |
Hypothyroidism |
Fatty liver |
Non-alcoholic steato-hepatitis |
- Citation: Mazzanti R, Arena U, Tassi R. Hepatocellular carcinoma: Where are we? World J Exp Med 2016; 6(1): 21-36
- URL: https://www.wjgnet.com/2220-315X/full/v6/i1/21.htm
- DOI: https://dx.doi.org/10.5493/wjem.v6.i1.21